Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Thorax ; 64(9): 744-8, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19158121

RESUMO

BACKGROUND: Analysis of exhaled breath, especially of volatile organic compounds (VOCs), is of increasing interest in the diagnosis of lung cancer. Compared with other methods of breath analysis, ion mobility spectrometry (IMS) offers a tenfold higher detection rate of VOCs. By coupling the ion mobility spectrometer with a multicapillary column as a pre-separation unit, IMS offers the advantage of an immediate twofold separation of VOCs with visualisation in a three-dimensional chromatogram. The total analysis time is about 500 s compared with gas chromatography/mass spectrometry (GC/MS) of about 1 h. It therefore seemed reasonable to test IMS in breath analysis. METHODS: In a pilot study, 32 patients with lung cancer were subjected to a breath analysis by IMS. Their IMS chromatograms were compared with those of 54 healthy controls. An IMS that was built for special clinical application was used to identify characteristic peaks of VOCs which might be relevant for the diagnosis of lung cancer in exhaled air of 10 ml volume. RESULTS: By a combination of 23 peak regions within the IMS chromatogram, patients with lung cancer, including a patient with carcinoma in situ, were classified and differentiated from healthy persons with an error rate of zero. CONCLUSION: Breath analysis by IMS can detect a discriminating combination of VOCs in patients with lung cancer. By pattern recognition without the need for chemical analysis of the underlying VOCs, IMS has the potential to facilitate lung cancer diagnosis.


Assuntos
Biomarcadores Tumorais/análise , Testes Respiratórios/métodos , Íons/análise , Neoplasias Pulmonares/diagnóstico , Espectrometria de Massas/métodos , Compostos Orgânicos Voláteis/análise , Idoso , Testes Respiratórios/instrumentação , Carcinoma in Situ/diagnóstico , Carcinoma Pulmonar de Células não Pequenas/diagnóstico , Métodos Epidemiológicos , Feminino , Humanos , Masculino , Espectrometria de Massas/instrumentação , Pessoa de Meia-Idade , Projetos Piloto , Carcinoma de Pequenas Células do Pulmão/diagnóstico
2.
Urologe A ; 38(4): 358-63, 1999 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-10444795

RESUMO

Aim of this case-control study, performed on 412 male bladder cancer cases and 414 controls with benign prostatic hyperplasia in a former area of coal, iron and steel industries in Germany, was to identify occupations with an increased bladder cancer risk. In bladder cancer cases, smokers were overrepresented (58.3%) compared to controls (35.2%). The percentage of patients who had stopped smoking for at least 10 years did not differ in cases (10.2%) and controls (9.7%). Significantly elevated smoking-adjusted bladder cancer odds ratios (MH) were observed in painters and lacquers (MH 2.24, 95% CI 1.07-5.13), chemistry-related occupations (MH 2.44, 95% CI 1.05-5.67), coke plant workers (MH 2.89, 95% CI 1.16-7.16) and hard coal miners (MH 2.33, 95% CI 1.52-3.58). Significantly decreased smoking-adjusted bladder cancer odds ratios (MH) were observed in businessmen (MH 0.64, 95% CI 0.45-0.92) and office personnel (MH 0.58, 95% CI 0.41-0.81). In these two groups a relevant exposure to occupational bladder carcinogens is not likely.


Assuntos
Carcinoma de Células de Transição/induzido quimicamente , Doenças Profissionais/induzido quimicamente , Exposição Ocupacional/efeitos adversos , Neoplasias da Bexiga Urinária/induzido quimicamente , Idoso , Carcinoma de Células de Transição/diagnóstico , Cocarcinogênese , Humanos , Masculino , Doenças Profissionais/diagnóstico , Fatores de Risco , Fumar/efeitos adversos , Neoplasias da Bexiga Urinária/diagnóstico
3.
Int J Occup Environ Health ; 4(2): 79-84, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-10026468

RESUMO

In a case-control study performed in an area of former coal, iron, and steel industries, the professional and lifestyle histories of 412 male urothelial bladder cancer inpatients (cases) and 414 inpatients with benign prostatic hyperplasia (controls) were investigated. Smoking habits were identified as the main confounder for occupational bladder cancer risk. Two hundred and forty (58.3%) of the bladder cancer inpatients and 146 (35.3%) of the inpatients with benign prostatic hyperplasia were smokers. The percentage of ex-smokers in the bladder cancer cases was 10.2%; the percentage of ex-smokers in the controls was 9.7%. Smoking-adjusted Mantel-Haenszel estimates of the odds ratios (OR&infMH;) for bladder cancer were elevated in underground hard-coal miners (OR&infMH; =2. 54, 95% CI =[1.64; 3.93]), chemical workers (OR&infMH; =2.16, 95% CI =[0.87; 5.38]), painters/varnishers (OR&infMH; = 2.42, 95% CI =[1. 05; 5.57]), technicians (OR&infMH; = 1.99, 95% CI =[0.95; 4.16]), and foundry workers (OR&infMH; = 2.22, 95% CI = [0.53; 9.08]). Administrative officers had significantly lower smoking-adjusted odds ratios (OR&infMH; = 0.61, 95% CI = [0.42; 0.88]). Although statistically not significant, the results of the Breslow-Day test of homogeneity of the odds ratios over the strata are compatible with interactions between tobacco smoking and the occupations of underground hard-coal miners (chi(2)&infBD; = 4.91, p=0.07) and chemical workers (chi(2)&infBR; = 3.32, p=0.06).


Assuntos
Minas de Carvão , Metalurgia , Doenças Profissionais/etiologia , Neoplasias da Bexiga Urinária/etiologia , Adulto , Estudos de Casos e Controles , Fatores de Confusão Epidemiológicos , Alemanha , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Hiperplasia Prostática/etiologia , Fatores de Risco , Fumar/efeitos adversos , Inquéritos e Questionários , Urotélio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA